title: Complete reversal of left ventricular mass in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia after therapy with imatinib.
authors.forename: Hans C
authors.initials: HC
authors.lastname: Volz
authors.forename: Celine
authors.initials: C
authors.lastname: Weiss
authors.forename: Dirk
authors.initials: D
authors.lastname: Lossnitzer
authors.forename: Alexandra R
authors.initials: AR
authors.lastname: Zankl
authors.forename: Jolanta B
authors.initials: JB
authors.lastname: Perz
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Dengler
authors.forename: Hugo A
authors.initials: HA
authors.lastname: Katus
authors.forename: Stefan E
authors.initials: SE
authors.lastname: Hardt
mesh_terms: D000328:Adult; D001549:Benzamides; D002908:Chronic Disease; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000175:diagnosis* / Q000188:drug therapy* / Q000235:genetics; D017379:Hypertrophy, Left Ventricular / Q000175:diagnosis* / Q000188:drug therapy* / Q000235:genetics; D000068877:Imatinib Mesylate; D008297:Male; D015514:Oncogene Proteins, Fusion / Q000096:biosynthesis*; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D020796:Receptor, Platelet-Derived Growth Factor alpha / Q000096:biosynthesis*; D016896:Treatment Outcome; D039221:mRNA Cleavage and Polyadenylation Factors / Q000096:biosynthesis*
chemical_list: D001549:Benzamides; D015514:Oncogene Proteins, Fusion; D010879:Piperazines; D011743:Pyrimidines; D039221:mRNA Cleavage and Polyadenylation Factors; D000068877:Imatinib Mesylate; C479819:FIP1L1-PDGFRA fusion protein, human; D020796:Receptor, Platelet-Derived Growth Factor alpha